High-dose folic acid study to support DNA-building pathways
Treatments studied
This study tests whether taking a high dose of folic acid changes body pathways involved in DNA (genetic material) formation. It may help researchers understand how folate affects cells, which could be relevant to health and growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy (no long-term medical conditions listed by the study).
- Your body mass index (BMI) is between 19 and 24.
- Your blood shows normal folate, and normal vitamin B12 and B6.
- You can swallow tablets and can receive an intravenous (IV) catheter if needed.
- You are not currently pregnant or breastfeeding.
- You have not used vitamin or supplement products like amino acid or protein supplements for more than 6 months before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a form of folic acid (5-methyltetrahydrofolate) can help people with fatty liver disease. It may improve liver health by supporting fat and sugar processing.
This study tests if a higher dose of folic acid (a B vitamin) before pregnancy helps prevent certain birth defects. If you are trying to get pregnant and are generally healthy, you may be able to join.
This study looks at how a vitamin called tetrahydrofolate may affect pregnancies with preeclampsia or increased risk of high blood pressure. Participants may receive the supplement to help researchers understand key biology and potential benefits or harms.
This trial tests how a supplement containing EPA (a type of omega-3 from fish oil) and a form of folate (vitamin B9) is absorbed by the body. It is for healthy people who are willing to follow a vegetarian diet during the study.
This trial tests whether a folate supplement called 5-MTHF can help people with type 1 diabetes. It is for those diagnosed within the last 5 years who still produce some insulin. The goal is to see if the supplement can preserve remaining insulin-making cells.
This study looks at whether a “methyl-donor” nutrient supplement changes metabolism (methylation) in people with lupus who are also in the childbearing age range and have low-to-moderate disease activity. It may help researchers understand why lupus acts differently in some people and how diet-related pathways could affect symptoms.
Hear when a new One-carbon Metabolism in Healthy Individuals trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.